Focal Adhesion Kinase (FAK) Mediates the Induction of Pro-Oncogenic and Fibrogenic Phenotypes in Hepatitis C Virus (HCV)-Infected Cells

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Alisi, Anna ^a   Arciello, Mario ^b,c   Petrini, Stefania ^a   Conti, Beatrice ^b,c   Missale, Gabriele ^d   Balsano, Clara ^b,e  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d UNIVERSITY HOSPITAL OF PARMA   (Italy)

^e IBPM (Institute of Biology and Molecular Pathology)   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ; ALPHA SMOOTH MUSCLE ACTIN; FOCAL ADHESION KINASE; HYALURONIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PAXILLIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOPLASM; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; GENE SILENCING; HEPATITIS C; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL MEMBRANE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; STELLATE CELL;

ACTININ; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HEPACIVIRUS; HEPATIC STELLATE CELLS; HEPATITIS C; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; PAXILLIN; TUMOR NECROSIS FACTOR-ALPHA;

HEPATITIS C VIRUS;

EID: 84865511211     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044147     Document Type: Article

References (52)

1. El-Serag HB, Rudolph KL, (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576.
2. Levrero M, (2006) Viral hepatitis and liver cancer: the case of hepatitis C. Oncogene. 25: 3834-3847.
3. Balsano C, Alisi A (2007) Hepatitis C virus (HCV): an RNA virus with a pro-oncogenic potential. Dig Liver Dis (Suppl 1): S46-51.
4. Balsano C, Alisi A, Nobili V, (2009) Liver fibrosis and therapeutic strategies: the goal for improving metabolism. Curr Drug Targets 2009 10: 505-512.
5. Alisi A, Giambartolomei S, Cupelli F, Merlo P, Fontemaggi G, et al. (2003) Physical and functional interaction between HCV core protein and the different p73 isoforms. Oncogene 22: 2573-2580.
6. Alisi A, Mele R, Spaziani A, Tavolaro S, Palescandolo E, et al. (2005) Thr 446 phosphorylation of PKR by HCV core protein deregulates G2/M phase in HCC cells. J Cell Physiol 205: 25-31.
7. Alisi A, Ghidinelli M, Zerbini A, Missale G, Balsano C, (2011) Hepatitis C virus and alcohol: Same mitotic targets but different signaling pathways. J Hepatol 54: 956-963.
8. Desmouliere A, Guyot C, Gabbiani G, (2004) The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 48: 509-517.
9. Yang JD, Nakamura I, Roberts LR, (2011) The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets. Semin Cancer Biol 21: 35-43.
10. Giannelli G, Quaranta V, Antonaci S, (2003) Tissue remodelling in liver diseases. Histol Histopathol 18: 1267-1274.
11. Wu XZ, Chen D, (2006) Cell-matrix talks: effects on differentiation of hepatocellular carcinoma. Minerva Gastroenterol Dietol 52: 407-413.
12. Izaguirre G, Aguirre L, Hu YP, Lee HY, Schlaepfer DD, (2001) et al. The cytoskeletal/non-muscle isoform of alpha-actinin is phosphorylated on its actin-binding domain by the focal adhesion kinase. J Biol Chem 276: 28676-28685.
13. Zhao J, Guan JL, (2009) Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 28: 35-49.
14. Itoh S, Maeda T, Shimada M, Aishima S, Shirabe K, et al. (2004) Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin Cancer Res 10: 2812-2817.
15. Fujii T, Koshikawa K, Nomoto S, Okochi O, Kaneko T, et al. (2004) Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor. J Hepatol 41: 104-111.
16. von Sengbusch A, Gassmann P, Fisch KM, Enns A, Nicolson GL, et al. (2005) Focal adhesion kinase regulates metastatic adhesion of carcinoma cells within liver sinusoids. Am J Pathol 166: 585-596.
17. Yuan Z, Zheng Q, Fan J, Ai KX, Chen J, et al. (2010) Expression and prognostic significance of focal adhesion kinase in hepatocellular carcinoma. J Cancer Res Clin Oncol 136: 1489-1496.
18. Chen JS, Huang XH, Wang Q, Chen XL, Fu XH, et al. (2010) FAK is involved in invasion and metastasis of hepatocellular carcinoma. Clin Exp Metastasis 27: 71-82.
19. de Chassey B, Navratil V, Tafforeau L, Hiet MS, Aublin-Gex A, et al. (2008) Hepatitis C virus infection protein network. Mol Syst Biol 4: 230.
20. Carloni V, Romanelli RG, Pinzani M, Laffi G, Gentilini P, (1997) Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. Gastroenterology 112: 522-531.
21. Jiang HQ, Zhang XL, Liu L, Yang CC, (2004) Relationship between focal adhesion kinase and hepatic stellate cell proliferation during rat hepatic fibrogenesis. World J Gastroenterol 10: 3001-3005.
22. Friedman SL, (2010) Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 7: 425-436.
23. Amann T, Bataille F, Spruss T, Mühlbauer M, Gäbele E, et al. (2009) Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma. Cancer Sci 100: 646-653.
24. Kato T, Date T, Murayama A, Morikawa K, Akazawa D, et al. (2006) Cell culture and infection system for hepatitis C virus. Nat Protoc 1: 2334-2339.
25. Lo SH, (2006) Focal adhesions: what's new inside. Dev Biol 294: 280-291.
26. Parsons JT, (2003) Focal adhesion kinase: the first ten years. J Cell Sci 116: 1409-1416.
27. Schaller MD, (2010) Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions. J Cell Sci; 123(Pt 7): 1007-1013.
28. Deakin NO, Turner CE, (2008) Paxillin comes of age. J Cell Sci 121(Pt 15): 2435-2444.
29. Reif S, Lang A, Lindquist JN, Yata Y, Gabele E, et al. (2003) The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression. J Biol Chem 278: 8083-8090.
30. Mon NN, Ito S, Senga T, Hamaguchi M, (2006) FAK signaling in neoplastic disorders: a linkage between inflammation and cancer. Ann N Y Acad Sci 1086: 199-212.
31. Tseng WP, Su CM, Tang CH, (2010) FAK activation is required for TNF-alpha-induced IL-6 production in myoblasts. J Cell Physiol 223: 389-396.
32. Mehal W, Imaeda A, (2010) Cell death and fibrogenesis. Semin Liver Dis 30: 226-231.
33. Tarrats N, Moles A, Morales A, García-Ruiz C, Fernández-Checa JC, et al. (2011) Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis. Hepatology 54: 319-327.
34. Boosani CS, Nalabothula N, Munugalavadla V, Cosgrove D, Keshamoun VG, et al. (2009) FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by alpha1(IV)NC1. Invest Ophthalmol Vis Sci 50: 4567-4575.
35. Dolganiuc A, Kodys K, Kopasz A, Marshall C, Do T, et al. (2003) Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol 170: 5615-5624.
36. Battaglia S, Benzoubir N, Nobilet S, Charneau P, Samuel D, et al. (2009) Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transition. PLoS One 4: e4355.
37. Clément S, Pascarella S, Conzelmann S, Gonelle-Gispert C, Guilloux K, et al. (2010) The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8. J Hepatol 52: 635-643.
38. Hosomura N, Kono H, Tsuchiya M, Ishii K, Ogiku M, et al. (2011) HCV-Related Proteins Activate Kupffer Cells Isolated from Human Liver Tissues. Dig Dis Sci 56: 1057-1064.
39. McGivern DR, Lemon SM, (2011) Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene 30: 1969-1983.
40. Yang JD, Nakamura I, Roberts LR, (2011) The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets. Semin Cancer Biol 21: 35-43.
41. Bai XM, Zhang W, Liu NB, Jiang H, Lou KX, et al. (2009) Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells. Oncol Rep 21: 129-136.
42. Fang C, Yi Z, Liu F, Lan S, Wang J, et al. (2006) Proteome analysis of human liver carcinoma Huh7 cells harboring hepatitis C virus subgenomic replicon. Proteomics 6: 519-527.
43. Li HG, Xie DR, Shen XM, Li HH, Zeng H, et al. (2005) Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma. World J Gastroenterol 11: 1445-1451.
44. Wu YM, Tang J, Zhao P, Chen ZN, Jiang JL, (2009) Enhanced expression of Hab18g/CD147 and activation of integrin pathway in HCC cells under 3-D co-culture conditions. Cell Biol Int 33: 199-206.
45. Sancho-Bru P, Juez E, Moreno M, Khurdayan V, Morales-Ruiz M, et al. (2010) Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepatic stellate cells. Liver Int 30: 31-41.
46. Neuman MG, Schmilovitz-Weiss H, Hilzenrat N, Bourliere M, Marcellin P, et al. (2012) Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C. Int J Hepatol. 2012: 231210.
47. González-Amaro R, García-Monzón C, García-Buey L, Moreno-Otero R, et al. (1994) Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med 179: 841-848.
48. Talaat RM, (2010) Soluble angiogenesis factors in sera of Egyptian patients with hepatitis C virus infection: correlation with disease severity. Viral Immunol 23: 151-157.
49. Li JT, Liao ZX, Ping J, Xu D, Wang H, (2008) Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies. J Gastroenterol 43: 419-428.
50. Ariumi Y, Kuroki M, Maki M, Ikeda M, Dansako H, et al. (2011) The ESCRT system is required for hepatitis C virus production. PLoS One 6: e14517.
51. Alisi A, Piemonte F, Pastore A, Panera N, Passarelli C, et al. (2009) Glutathionylation of p65NF-kappaB correlates with proliferating/apoptotic hepatoma cells exposed to pro- and anti-oxidants. Int J Mol Med 24: 319-326.
52. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.